Investigational agents
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Investigational agents, covering 2026-07-01 to 2026-07-01. Get the full timeline:
Most recent: Clinical Trial Results: Efficacy and Safety of Pembrolizumab Plus Investigational Agents in Combination With Chemotherapy as First-Line Treatment in Extensive-Stage Small Cell Lung Cancer (ES-SCLC) (MK-3475-B99/ KEYNOTE-B99) [Phase 2]